Knoll Capital Management, LLC Diversified Active

CIK: 0001325083 · Show all filings

Period: Q2 2014 (← Previous) (Next →)

Filing Date: Aug 14, 2014

Total Value ($000): $224,399 (100.0% shares, 0.0% debt)

Holdings (15)

— Medivation, Inc. 78.3%

Value ($000) $175,705 Shares 2,279,519 Est. Cost $49.20 Unrealized —

— Ampio Pharmaceuticals Inc. 11.0%

Value ($000) $24,753 Shares 2,964,401 Est. Cost $6.37 Unrealized —

— Alcobra Ltd 5.3%

Value ($000) $11,892 Shares 687,000 Est. Cost $8.47 Unrealized —

— Keryx Biopharmaceuticals Inc. 1.4%

Value ($000) $3,076 Shares 200,000 Est. Cost $10.21 Unrealized —

— Synthetic Biologics Inc. 1.1%

Value ($000) $2,394 Shares 1,360,000 Est. Cost $1.51 Unrealized —

— Newlink Genetics Corp 0.9%

Value ($000) $2,056 Shares 77,437 Est. Cost $19.35 Unrealized —

NWBO Northwest Biotherapeutics Inc 0.6%

Value ($000) $1,344 Shares 200,300 Est. Cost $5.93 Unrealized +7.4%

— Inovio Pharmaceuticals Inc. 0.5%

Value ($000) $1,109 Shares 102,088 Est. Cost $10.86 Unrealized —

— Advaxis Inc. 0.3%

Value ($000) $709 Shares 225,000 Est. Cost $4.21 Unrealized —

— Galmed Pharmaceuticals Ltd 0.3%

Value ($000) $633 Shares 65,000 Est. Cost $11.48 Unrealized —

— Nephrogenex Inc 0.1%

Value ($000) $301 Shares 50,000 Est. Cost $8.24 Unrealized —

PVCT Provectus Biopharmaceuticals 0.1%

Value ($000) $172 Shares 200,000 Est. Cost $1.90 Unrealized 0.0%

— Advaxis Inc. 0.1%

Value ($000) $115 Shares 112,500 Est. Cost $1.65 Unrealized —

— Celsus Therapeutics Plc 0.0%

Value ($000) $78 Shares 14,155 Est. Cost $6.49 Unrealized —

— Echo Therapeutics Inc. 0.0%

Value ($000) $62 Shares 27,430 Est. Cost $0.25 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Medivation, Inc.	2,279,519	$175,705	78.3%	$49.20	—	Com	58501N101
—	Ampio Pharmaceuticals Inc.	2,964,401	$24,753	11.0%	$6.37	—	Com	03209T109
—	Alcobra Ltd	687,000	$11,892	5.3%	$8.47	—	SHS	M2239P109
—	Keryx Biopharmaceuticals Inc.	200,000	$3,076	1.4%	$10.21	—	Com	492515101
—	Synthetic Biologics Inc.	1,360,000	$2,394	1.1%	$1.51	—	COM	87164U102
—	Newlink Genetics Corp	77,437	$2,056	0.9%	$19.35	—	Com	651511107
NWBO	Northwest Biotherapeutics Inc	200,300	$1,344	0.6%	$5.93	+7.4%	COM PAR $0.001	66737P600
—	Inovio Pharmaceuticals Inc.	102,088	$1,109	0.5%	$10.86	—	COM NEW	45773H201
—	Advaxis Inc.	225,000	$709	0.3%	$4.21	—	COM NEW	7624208
—	Galmed Pharmaceuticals Ltd	65,000	$633	0.3%	$11.48	—	SHS	M47238106
—	Nephrogenex Inc	50,000	$301	0.1%	$8.24	—	COMM	640667101
PVCT	Provectus Biopharmaceuticals	200,000	$172	0.1%	$1.90	0.0%	COM	74373P108
—	Advaxis Inc.	112,500	$115	0.1%	$1.65	—	W EXP 07/15/201	7624117
—	Celsus Therapeutics Plc	14,155	$78	0.0%	$6.49	—	SPONSORED ADR NE	15119A202
—	Echo Therapeutics Inc.	27,430	$62	0.0%	$0.25	—	Com New	27876L206